G2B’s Founders

Meritxell Teixidó, PhD
Chief Executive & Scientific Officer

With more than 10 years of experience in the field of brain drug delivery.
  • Peptide chemistry
  • Drug delivery technologies
  • Blood-brain barrier transport studies
  • Leadership of high-performance teams
  • Executive management

Gloria Sanclimens, PhD
Chief Operating Officer

With more than 14 years of experience in pharma industry.
  • R&D and innovation expert
  • Drug substance and Drug product development of NCE, Generic, OTC, Food supplements and Cosmetics products
  • CMC development for several EU countries, US, LATAM, Russia and Japan
  • In-licensing and project management

Esther Riambau, BSc, MBA
Business Development Advisor

With more than 18 years of experience in business development.
  • Fundraising
  • Business development
  • Licensing-out
  • Technology-based entrepreneurship
  • Strategic planning
  • Business modeling


Andres Morales La Madrid,

Clinical Director, Pediatric Oncology
Pediatric Neuro Oncology Unit,
Hospital Sant Joan de Déu, Barcelona

Andrés G. Fernández, PhD
Biopharma Industry Expert

Ernest Giralt, Prof.
Emeritus Professor at the Institute for Research in Biomedicine (IRB Barcelona)  and at the University of Barcelona

Fernando Albericio, Prof.
Professor at the University of KwaZulu-Natal and the University of Barcelona

Pablo Magnani
COO at TOWA Pharma International

Gloria García
Head of Fundraising, Hospital Sant Joan de Déu, Barcelona

Dr. Dirk Groenewegen
EIC Coach

Elena Canetti
Life Science Strategy Advisor

Ricard Casanovas
Pediatric Patients and Families Advocate



Gate2Brain will promote important core values within the team:

Gate2Brain thanks
the support of:


The contract is part of the grant PTQ2022-012493 financed by the MCIU/AEI/10.13039/501100011033


Gate2Brain SL has been the beneficiary of a project subsidized by the CDTI with the collaboration of the Ministry of Science and Innovation and co-financed by the European Union – Next Generation EU. File number SNEO-20211130.